Sohonos (palovarotene)

pCPA File Number: 22384

Negotiation Status:

Under consideration for negotiation

Indication(s):

to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with Fibrodysplasia (myositis) Ossificans Progressiva

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals Canada, Inc.

CADTH Project Number:

SR0761

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable